45 results
Page 2 of 3
8-K
EX-99.1
in2kinbqxp4qfb2 4hp
9 Nov 20
Intra-cellular Therapies Reports Third Quarter 2020 Financial Results and Provides Corporate Update
7:40am
8-K
EX-1.1
w1xhhbr5h0tw
11 Sep 20
Entry into a Material Definitive Agreement
4:47pm
424B5
0x9xpomhk1rv l9
11 Sep 20
Prospectus supplement for primary offering
4:44pm
424B5
ntlk 9i1ys
9 Sep 20
Prospectus supplement for primary offering
4:40pm
8-K
EX-99.1
0olrtn3eu 405
10 Aug 20
Intra-cellular Therapies Reports Second Quarter 2020 Financial Results and Provides Corporate Update
7:52am
8-K
EX-99.1
e78voi
7 May 20
Intra-cellular Therapies Reports First Quarter 2020 Financial Results and Provides Corporate Update
7:42am
DEFA14A
c5iaom4gjq2ycfkf9aq
9 Apr 20
Additional proxy soliciting materials
4:05pm
8-K
EX-1.1
s2i2zgb5fohja3b6
8 Jan 20
Entry into a Material Definitive Agreement
5:12pm
424B5
ep99e7
8 Jan 20
Prospectus supplement for primary offering
5:06pm
8-K
EX-99.3
096nmhmd glil
6 Jan 20
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
4:52pm
424B5
00zpq wipf
6 Jan 20
Prospectus supplement for primary offering
4:42pm
S-3ASR
jcfpolx 8qlbd5r
6 Jan 20
Automatic shelf registration
4:02pm
DEFA14A
g1keox7nlcbl3pe5e2
30 Apr 19
Additional proxy soliciting materials
4:19pm
DEFA14A
tedrbbi37kpf73m
27 Apr 18
Additional proxy soliciting materials
4:06pm